Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older
- People whose lung tumour is smaller than 3 centimetres in size
- People who have been diagnosed with Stage 1 Non-Small Cell Lung Cancer (an early-stage form of lung cancer)
- People whose scan results show the tumour is contained within one small section of the lung, meaning a surgeon could remove just that section rather than a larger portion
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a known sensitivity or allergic reaction to ICG (a medical dye), sodium iodide, or iodine
- Women who are currently pregnant or breastfeeding, or women who could become pregnant and are not currently using adequate contraception
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Waël C Hanna, MDCM, MBA, FRCSC, St. Joseph's Healthcare Hamilton / McMaster University
Phone: 905-522-1155
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phase I: Feasibility of the operation; Phase I: Safety of the operation; Phase I: Surgeon's learning curve; Phase II: Rate of conversion to robotic lobectomy in each arm
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.